Martin Shkreli, the CEO of Turing Pharmaceuticals, purchased the drug Daraprim and then promptly increased the price by more than 5,000 percent from $13.50 to $750 per pill. Besides this price-gouging move, he was recently arrested for securities fraud.
As the investigation digs deeper, it is quite possible that:
A. there were no other ethical gray areas created in his company.
B. he set ethical standards that inspired employees to shoot for higher critical.
C. this CEO's unethical actions influenced other company employees to take unethical actions.
+4
Answers (1)
Know the Answer?
Not Sure About the Answer?
Find an answer to your question 👍 “Martin Shkreli, the CEO of Turing Pharmaceuticals, purchased the drug Daraprim and then promptly increased the price by more than 5,000 ...” in 📗 Business if the answers seem to be not correct or there’s no answer. Try a smart search to find answers to similar questions.
Home » Business » Martin Shkreli, the CEO of Turing Pharmaceuticals, purchased the drug Daraprim and then promptly increased the price by more than 5,000 percent from $13.50 to $750 per pill.